查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1713705

迷走神經刺激全球市場報告 2025

Vagus Nerve Stimulation Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

迷走神經刺激市場規模預計在未來幾年將快速成長。到 2029 年，這一數字將成長至 17.6 億美元，年複合成長率（CAGR）為 14.6%。預測期內的成長歸因於抗治療性憂鬱症盛行率的增加、微創神經外科手術的採用率的增加、研發 (R&D)舉措的增加、醫療保健基礎設施的改善以及神經系統疾病盛行率和發病率的增加。預測期內的關鍵趨勢包括技術進步、產品設計創新、機器人輔助植入物、電刺激設備以及刺激技術創新。

預計未來幾年神經系統疾病盛行率的上升將推動迷走神經刺激市場的成長。神經系統疾病是一種影響大腦、脊髓和神經的疾病，導致運動、感覺、認知和整體功能出現問題。這些疾病的病因多種多樣，通常涉及遺傳、環境和生活方式因素的綜合作用。此外，頭部創傷或脊髓損傷等身體傷害也可能導致神經系統問題。迷走神經刺激可以透過調節大腦活動和神經傳導物質水平來幫助控制這些疾病，有助於緩解與癲癇、憂鬱症和某些類型的偏頭痛等疾病相關的症狀。例如，2024 年 9 月，澳洲政府機構澳洲健康與福利研究所估計，2023 年約有 411,100 名澳洲人將患有失智症，並預測到 2058 年這一數字將增加一倍以上。因此，神經系統疾病盛行率的不斷上升正在推動迷走神經刺激市場的成長。

迷走神經刺激市場的關鍵參與者正在開發先進產品，例如植入式脈衝產生器 (IPG)，以提供長期、可調節、標靶治療。植入式脈衝產生器 (IPG) 是一種植入皮下的裝置，可發射電脈衝來治療慢性疼痛和神經病變等疾病。例如，2023 年 2 月，英國醫療設備公司 LivaNova Plc 推出了 SenTiva DUO，這是一家專注於針對藥物難治性癲癇的迷走神經刺激 (VNS) 療法的 IPG。該設備允許使用舊式雙針系統的患者進行升級而無需更換導線，並提供具有可自訂自動輸送功能的先進 VNS 治療。 Sentiva DUO 透過增強癲癇控制和支持更好的治療依從性，代表了這些疾病管理的重大進步。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、新冠疫情、經濟復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球迷走神經刺激PESTEL分析（政治、社會、科技、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球迷走神經刺激市場：成長率分析
  • 全球迷走神經刺激市場表現：規模與成長，2019-2024
  • 全球迷走神經刺激市場預測：規模與成長，2024-2029 年，2034 年
  • 全球迷走神經刺激總目標市場（TAM）

第6章市場區隔

  • 全球迷走神經刺激市場：依產品、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 植入式迷走神經刺激裝置
  • 外部迷走神經刺激裝置
  • 全球迷走神經刺激市場生醫材料、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 金屬
  • 陶瓷
  • 聚合物
  • 全球迷走神經刺激市場：按應用、表現和預測，2019-2024 年、2024-2029 年、2034 年
  • 癲癇
  • 憂鬱症
  • 偏頭痛
  • 全球迷走神經刺激市場：按最終用途、表現和預測，2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 神經科診所
  • 門診手術中心
  • 研究中心
  • 全球迷走神經刺激市場植入式迷走神經刺激裝置細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 脈衝發生器
  • 導線和電極
  • 可充電植入設備
  • 不可充電植入式設備
  • 全球迷走神經刺激市場外部迷走神經刺激設備細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 經皮迷走神經刺激裝置
  • 穿戴式迷走神經刺激裝置
  • 可攜式體外刺激器
  • 家用VNS設備

第7章 區域和國家分析

  • 全球迷走神經刺激市場：依地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球迷走神經刺激市場：依國家、表現及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章競爭格局與公司概況

  • 迷走神經刺激市場：競爭格局
  • 迷走神經刺激市場：公司簡介
    • Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
    • Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Dignity Health Overview, Products and Services, Strategy and Financial Analysis
    • LivaNova LLC Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

  • NeuroTek Inc.
  • Neurospace Inc.
  • ReShape Lifesciences Inc.
  • electroCore Inc.
  • Adriakaim Inc.
  • Soterix Medical Inc.
  • Nexstim PLC
  • Cleveland Medical Devices Inc.
  • MicroTransponder Inc.
  • Parasym Ltd.
  • Neuvana LLC
  • NeuroSigma Inc.
  • Evren Technologies Inc.
  • Integrative Health Technologies Inc.
  • Aucta Technologies Inc

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

  • 迷走神經刺激市場 2029：提供新機會的國家
  • 迷走神經刺激市場 2029：細分市場帶來新機會
  • 迷走神經刺激市場2029：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第36章 附錄

簡介目錄
Product Code: r33607

Vagus nerve stimulation (VNS) is a medical treatment that involves delivering electrical impulses to the vagus nerve, a major nerve extending from the brainstem to the abdomen. This treatment affects various bodily functions, including heart rate, digestion, and mood regulation. It is primarily used to manage conditions such as epilepsy, treatment-resistant depression, and other neurological disorders.

The main products for vagus nerve stimulation include implantable VNS devices and external VNS devices. An implantable VNS device is surgically placed in the body, typically in the neck, to deliver electrical impulses to the vagus nerve. It is designed using various biomaterials, such as metals, ceramics, and polymers, and is used for treating epilepsy, depression, and migraines. These devices are utilized in several settings, including hospitals, neurology clinics, ambulatory surgical centers, and research institutions.

The vagus nerve stimulation market research report is one of a series of new reports from The Business Research Company that provides vagus nerve stimulation market statistics, including vagus nerve stimulation industry global market size, regional shares, competitors with a vagus nerve stimulation market share, detailed vagus nerve stimulation market segments, market trends and opportunities, and any further data you may need to thrive in the vagus nerve stimulation industry. This vagus nerve stimulation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The vagus nerve stimulation market size has grown rapidly in recent years. It will grow from $0.89 billion in 2024 to $1.02 billion in 2025 at a compound annual growth rate (CAGR) of 14.9%. The growth in the historic period can be attributed to rising geriatric population, prevalence of depression, increasing awareness and acceptance of alternative therapies, growing prevalence of epilepsy, and increasing incidence of chronic diseases.

The vagus nerve stimulation market size is expected to see rapid growth in the next few years. It will grow to $1.76 billion in 2029 at a compound annual growth rate (CAGR) of 14.6%. The growth in the forecast period can be attributed to the growing prevalence of treatment-resistant depression, rising adoption of minimally invasive neurosurgical procedures, rising research and development (R&D) initiatives, improving healthcare infrastructure, and increasing prevalence and incidence of neurological disorders. Major trends in the forecast period include technological advancements, innovations in product design, robot-assisted implantation, electrical stimulation devices, and innovating stimulation techniques.

The rising prevalence of neurological disorders is expected to drive the growth of the vagus nerve stimulation market in the coming years. Neurological disorders are conditions that impact the brain, spinal cord, or nerves, resulting in issues with movement, sensation, cognition, or overall functionality. The causes of these disorders are varied, often involving a combination of genetic, environmental, and lifestyle factors. Moreover, physical injuries, such as head trauma and spinal cord injuries, can also lead to neurological issues. Vagus nerve stimulation is utilized to manage these disorders by modulating brain activity and neurotransmitter levels, which helps alleviate symptoms associated with conditions such as epilepsy, depression, and specific types of migraines. For instance, in September 2024, the Australian Institute of Health and Welfare, a government agency in Australia, estimated that approximately 411,100 Australians were living with dementia in 2023, with projections indicating that this number will more than double by 2058. Thus, the increasing prevalence of neurological disorders is fueling the growth of the vagus nerve stimulation market.

Key players in the vagus nerve stimulation market are developing advanced products such as implantable pulse generators (IPGs) to provide long-term, adjustable, and targeted therapy for chronic conditions. An implantable pulse generator (IPG) is a device implanted under the skin that delivers electrical pulses to treat conditions such as chronic pain or neurological disorders. For example, in February 2023, LivaNova Plc, a UK-based medical device company, introduced the SenTiva DUO, a specialized IPG for vagus nerve stimulation (VNS) therapy aimed at drug-resistant epilepsy. This device allows patients with older dual-pin systems to upgrade without lead revisions, offering advanced VNS therapy with customizable and automatic delivery. The SenTiva DUO enhances seizure control and supports better treatment adherence, marking a significant advancement in managing these conditions.

In June 2023, SCREEN Holdings Co. Ltd., a semiconductor company based in Japan, acquired shares in Adriakaim Inc. for an undisclosed amount. Following this acquisition, SCREEN plans to work with Adriakaim to accelerate the commercialization of its vagus nerve stimulation devices. SCREEN will also continue to address various needs within the medical field, contributing to solutions for societal issues. Adriakaim Inc. is a Japanese manufacturer specializing in vagus nerve stimulation devices.

Major companies operating in the vagus nerve stimulation market are Medtronic PLC, Stryker Corporation, Boston Scientific Corporation, Dignity Health, LivaNova LLC, NeuroTek Inc., Neurospace Inc., ReShape Lifesciences Inc., electroCore Inc., Adriakaim Inc., Soterix Medical Inc., Nexstim PLC, Cleveland Medical Devices Inc., MicroTransponder Inc., Parasym Ltd., Neuvana LLC, NeuroSigma Inc., Evren Technologies Inc., Integrative Health Technologies Inc., Aucta Technologies Inc

North America was the largest region in the vagus nerve stimulation market in 2023. The regions covered in the vagus nerve stimulation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the vagus nerve stimulation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The vagus nerve stimulation market consists of sales of non-invasive VNS devices, stimulation generators, lead wires and electrodes, rechargeable VNS devices and wearable VNS patches. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Vagus Nerve Stimulation Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on vagus nerve stimulation market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for vagus nerve stimulation ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The vagus nerve stimulation market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Implantable Vagus Nerve Stimulation Device; External Vagus Nerve Stimulation Device
  • 2) By Biomaterial: Metallic; Ceramics; Polymeric
  • 3) By Application: Epilepsy; Depression; Migraine
  • 4) By End-Use: Hospitals; Neurology Clinics; Ambulatory Surgical Centers; Research Centers
  • Subsegments:
  • 1) By Implantable Vagus Nerve Stimulation Device: Pulse Generators; Leads and Electrodes; Rechargeable Implantable Devices; Non-Rechargeable Implantable Devices
  • 2) By External Vagus Nerve Stimulation Device: Transcutaneous Vagus Nerve Stimulation Devices; Wearable VNS Devices; Portable External Stimulators; Home-use VNS Devices
  • Companies Mentioned: Medtronic PLC; Stryker Corporation; Boston Scientific Corporation; Dignity Health; LivaNova LLC
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Vagus Nerve Stimulation Market Characteristics

3. Vagus Nerve Stimulation Market Trends And Strategies

4. Vagus Nerve Stimulation Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Vagus Nerve Stimulation Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Vagus Nerve Stimulation PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Vagus Nerve Stimulation Market Growth Rate Analysis
  • 5.4. Global Vagus Nerve Stimulation Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Vagus Nerve Stimulation Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Vagus Nerve Stimulation Total Addressable Market (TAM)

6. Vagus Nerve Stimulation Market Segmentation

  • 6.1. Global Vagus Nerve Stimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Implantable Vagus Nerve Stimulation Device
  • External Vagus Nerve Stimulation Device
  • 6.2. Global Vagus Nerve Stimulation Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Metallic
  • Ceramics
  • Polymeric
  • 6.3. Global Vagus Nerve Stimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Epilepsy
  • Depression
  • Migraine
  • 6.4. Global Vagus Nerve Stimulation Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Neurology Clinics
  • Ambulatory Surgical Centers
  • Research Centers
  • 6.5. Global Vagus Nerve Stimulation Market, Sub-Segmentation Of Implantable Vagus Nerve Stimulation Device, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pulse Generators
  • Leads and Electrodes
  • Rechargeable Implantable Devices
  • Non-Rechargeable Implantable Devices
  • 6.6. Global Vagus Nerve Stimulation Market, Sub-Segmentation Of External Vagus Nerve Stimulation Device, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Transcutaneous Vagus Nerve Stimulation Devices
  • Wearable VNS Devices
  • Portable External Stimulators
  • Home-use VNS Devices

7. Vagus Nerve Stimulation Market Regional And Country Analysis

  • 7.1. Global Vagus Nerve Stimulation Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Vagus Nerve Stimulation Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Vagus Nerve Stimulation Market

  • 8.1. Asia-Pacific Vagus Nerve Stimulation Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Vagus Nerve Stimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Vagus Nerve Stimulation Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Vagus Nerve Stimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Vagus Nerve Stimulation Market

  • 9.1. China Vagus Nerve Stimulation Market Overview
  • 9.2. China Vagus Nerve Stimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Vagus Nerve Stimulation Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Vagus Nerve Stimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Vagus Nerve Stimulation Market

  • 10.1. India Vagus Nerve Stimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Vagus Nerve Stimulation Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Vagus Nerve Stimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Vagus Nerve Stimulation Market

  • 11.1. Japan Vagus Nerve Stimulation Market Overview
  • 11.2. Japan Vagus Nerve Stimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Vagus Nerve Stimulation Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Vagus Nerve Stimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Vagus Nerve Stimulation Market

  • 12.1. Australia Vagus Nerve Stimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Vagus Nerve Stimulation Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Vagus Nerve Stimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Vagus Nerve Stimulation Market

  • 13.1. Indonesia Vagus Nerve Stimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Vagus Nerve Stimulation Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Vagus Nerve Stimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Vagus Nerve Stimulation Market

  • 14.1. South Korea Vagus Nerve Stimulation Market Overview
  • 14.2. South Korea Vagus Nerve Stimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Vagus Nerve Stimulation Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Vagus Nerve Stimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Vagus Nerve Stimulation Market

  • 15.1. Western Europe Vagus Nerve Stimulation Market Overview
  • 15.2. Western Europe Vagus Nerve Stimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Vagus Nerve Stimulation Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Vagus Nerve Stimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Vagus Nerve Stimulation Market

  • 16.1. UK Vagus Nerve Stimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Vagus Nerve Stimulation Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Vagus Nerve Stimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Vagus Nerve Stimulation Market

  • 17.1. Germany Vagus Nerve Stimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Vagus Nerve Stimulation Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Vagus Nerve Stimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Vagus Nerve Stimulation Market

  • 18.1. France Vagus Nerve Stimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Vagus Nerve Stimulation Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Vagus Nerve Stimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Vagus Nerve Stimulation Market

  • 19.1. Italy Vagus Nerve Stimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Vagus Nerve Stimulation Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Vagus Nerve Stimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Vagus Nerve Stimulation Market

  • 20.1. Spain Vagus Nerve Stimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Vagus Nerve Stimulation Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Vagus Nerve Stimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Vagus Nerve Stimulation Market

  • 21.1. Eastern Europe Vagus Nerve Stimulation Market Overview
  • 21.2. Eastern Europe Vagus Nerve Stimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Vagus Nerve Stimulation Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Vagus Nerve Stimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Vagus Nerve Stimulation Market

  • 22.1. Russia Vagus Nerve Stimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Vagus Nerve Stimulation Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Vagus Nerve Stimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Vagus Nerve Stimulation Market

  • 23.1. North America Vagus Nerve Stimulation Market Overview
  • 23.2. North America Vagus Nerve Stimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Vagus Nerve Stimulation Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Vagus Nerve Stimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Vagus Nerve Stimulation Market

  • 24.1. USA Vagus Nerve Stimulation Market Overview
  • 24.2. USA Vagus Nerve Stimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Vagus Nerve Stimulation Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Vagus Nerve Stimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Vagus Nerve Stimulation Market

  • 25.1. Canada Vagus Nerve Stimulation Market Overview
  • 25.2. Canada Vagus Nerve Stimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Vagus Nerve Stimulation Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Vagus Nerve Stimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Vagus Nerve Stimulation Market

  • 26.1. South America Vagus Nerve Stimulation Market Overview
  • 26.2. South America Vagus Nerve Stimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Vagus Nerve Stimulation Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Vagus Nerve Stimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Vagus Nerve Stimulation Market

  • 27.1. Brazil Vagus Nerve Stimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Vagus Nerve Stimulation Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Vagus Nerve Stimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Vagus Nerve Stimulation Market

  • 28.1. Middle East Vagus Nerve Stimulation Market Overview
  • 28.2. Middle East Vagus Nerve Stimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Vagus Nerve Stimulation Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Vagus Nerve Stimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Vagus Nerve Stimulation Market

  • 29.1. Africa Vagus Nerve Stimulation Market Overview
  • 29.2. Africa Vagus Nerve Stimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Vagus Nerve Stimulation Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Vagus Nerve Stimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Vagus Nerve Stimulation Market Competitive Landscape And Company Profiles

  • 30.1. Vagus Nerve Stimulation Market Competitive Landscape
  • 30.2. Vagus Nerve Stimulation Market Company Profiles
    • 30.2.1. Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Dignity Health Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. LivaNova LLC Overview, Products and Services, Strategy and Financial Analysis

31. Vagus Nerve Stimulation Market Other Major And Innovative Companies

  • 31.1. NeuroTek Inc.
  • 31.2. Neurospace Inc.
  • 31.3. ReShape Lifesciences Inc.
  • 31.4. electroCore Inc.
  • 31.5. Adriakaim Inc.
  • 31.6. Soterix Medical Inc.
  • 31.7. Nexstim PLC
  • 31.8. Cleveland Medical Devices Inc.
  • 31.9. MicroTransponder Inc.
  • 31.10. Parasym Ltd.
  • 31.11. Neuvana LLC
  • 31.12. NeuroSigma Inc.
  • 31.13. Evren Technologies Inc.
  • 31.14. Integrative Health Technologies Inc.
  • 31.15. Aucta Technologies Inc

32. Global Vagus Nerve Stimulation Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Vagus Nerve Stimulation Market

34. Recent Developments In The Vagus Nerve Stimulation Market

35. Vagus Nerve Stimulation Market High Potential Countries, Segments and Strategies

  • 35.1 Vagus Nerve Stimulation Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Vagus Nerve Stimulation Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Vagus Nerve Stimulation Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
  • 250423_r33607_Vagus_Nerve_Stimulation_GMR_2025